Is Dexedrine (dextroamphetamine) more potent than Adderall (mixed amphetamine salts)?

Dexedrine vs. Adderall Potency

Dexedrine (dextroamphetamine) is approximately twice as potent as Adderall (mixed amphetamine salts) on a milligram-per-milligram basis, meaning you need roughly half the dose of dextroamphetamine to achieve equivalent therapeutic effects. This difference stems from Adderall containing only 75% active dextroamphetamine (the therapeutically superior isomer) mixed with 25% levoamphetamine, whereas Dexedrine is 100% dextroamphetamine. 1

Dosing Equivalence and Clinical Implications

Standard Dose Conversion

• The American Academy of Child and Adolescent Psychiatry recommends starting dextroamphetamine at 2.5 mg compared to 5 mg for mixed amphetamine salts, reflecting the 2:1 potency ratio. 1
• Maximum daily doses follow this same pattern: 40 mg for dextroamphetamine versus 60-65 mg for mixed amphetamine salts in adults, maintaining the approximate 2:1 conversion. 1
• When titrating, dextroamphetamine increases by 2.5-5 mg increments weekly, while Adderall increases by 5-10 mg increments, again reflecting the potency difference. 1

Pharmacokinetic Differences Beyond Potency

• Dextroamphetamine has a longer elimination half-life than mixed amphetamine salts, resulting in greater effects on appetite suppression and sleep disturbance despite lower milligram dosing. 1
• The levoamphetamine component in Adderall contributes more peripheral sympathetic effects (cardiovascular stimulation) with less central therapeutic benefit, meaning dextroamphetamine provides "cleaner" dopaminergic effects at lower doses. 1

Clinical Response Rates and Efficacy

Comparative Effectiveness

• Both medications achieve 70-80% response rates when properly titrated, with effect sizes around 1.0, indicating no clinically meaningful difference in overall efficacy despite the potency difference. 1, 2
• Approximately 40% of patients respond to both amphetamine formulations, while another 40% respond preferentially to only one, suggesting individual variation matters more than the potency difference. 1

Duration of Action Considerations

• In a head-to-head comparison, immediate-release dextroamphetamine (Dexedrine) demonstrated more sustained effects lasting 3-6 hours longer than immediate-release Adderall on certain measures, particularly academic performance tasks. 3
• Dextroamphetamine Spansules (extended-release) showed less robust morning effects compared to Adderall but maintained therapeutic benefits up to 12 hours post-dose on parent ratings and activity measures. 3

Practical Prescribing Guidance

When to Choose Dexedrine Over Adderall

• Select dextroamphetamine when patients experience excessive cardiovascular side effects (tachycardia, hypertension) on Adderall, as the absence of levoamphetamine reduces peripheral sympathetic stimulation. 1
• Consider dextroamphetamine for patients requiring extended afternoon/evening coverage, as its longer half-life provides more sustained symptom control. 1, 3
• Use dextroamphetamine when fine-tuning doses in the lower therapeutic range (2.5 mg increments allow more precise titration than 5 mg Adderall increments). 1

Monitoring Parameters Remain Identical

• Measure blood pressure and pulse at baseline and each visit during titration, as both medications elevate these parameters (average increases of 1-4 mmHg BP and 1-2 bpm heart rate). 1, 4
• Track appetite, sleep quality, and weight at every visit, with particular vigilance for dextroamphetamine given its longer half-life and greater propensity for these effects. 1
• Obtain weekly ADHD symptom ratings during dose optimization to ensure the lower milligram doses of dextroamphetamine are achieving equivalent symptom control. 1

Common Prescribing Pitfalls

Avoid Under-Dosing Due to Potency Confusion

• Do not assume that because dextroamphetamine is "more potent," lower doses will automatically suffice—systematic titration to optimal symptom control is required regardless of which amphetamine is prescribed. 1
• The 2:1 potency ratio is a starting point for conversion, but individual patients may require different relative doses based on metabolism, comorbidities, and symptom patterns. 1

Do Not Switch Formulations Without Proper Conversion

• When converting from Adderall to Dexedrine, divide the total daily Adderall dose by 2 as the initial dextroamphetamine dose, then titrate based on response rather than assuming exact equivalence. 1
• Monitor closely during the first 2 weeks after switching, as the longer half-life of dextroamphetamine may produce different peak-trough patterns and side-effect profiles. 1, 3

Recognize That "Potency" Does Not Equal "Efficacy"

• The higher milligram-per-milligram potency of dextroamphetamine does not translate to superior clinical outcomes—both medications achieve identical response rates and effect sizes when dosed appropriately. 1, 2
• Choice between formulations should be based on side-effect profile, duration of action needs, and individual response patterns rather than potency alone. 1, 3